1 / 18

Mixing and Injection System for Polyurethane Foam Scaffolds

Mixing and Injection System for Polyurethane Foam Scaffolds. Michael Scherer Dustin Dowell Andrew Solomon. March 13 th , 2008. Design Objectives. Novel device which effectively mixes two-component polyurethane foam scaffolds for bone injection in situ

sigourney-appleby
Télécharger la présentation

Mixing and Injection System for Polyurethane Foam Scaffolds

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mixing and Injection System for Polyurethane Foam Scaffolds Michael Scherer Dustin Dowell Andrew Solomon March 13th, 2008

  2. Design Objectives • Novel device which effectively mixes two-component polyurethane foam scaffolds for bone injection in situ • Transfer of composite from mixing device to injection device • Design must have practical use in the OR

  3. Background • Indications:  Minimally invasive techniques • Small bone fractures (i.e. distal radius fracture) • Osteoporotic fractures • Vertebral compression fractures • Bone cancer repairs (void filler) • Antibiotic delivery • Growth hormone delivery

  4. Current State-of-The-Art • ~1 million hospitalizations due to bone fractures per year in the United States • 700,000 of these per year are treated via autogenous bone graft (within same patient) • Limited donor bone tissue • Increased risk of pain and morbidity at donor site  Demand for synthetic material that is safe and effective

  5. Market Forecast • Capture 10% market share ~70,000 procedures per year • Cost of system (including mixer): $300 • Retail price: $1500 (approx.) • Total Revenue: $105,000,000 • Total Profit = $84,000,000

  6. Polyurethane Constituents • Isocyanate • Hardener • Polyol • Water • Catalyst • Stabilizer • Pore opener Polyol + isocyanate  polyurethane Water + isocyanate  CO2 (helps pores form)

  7. Polyurethane Variables • Polyol – 1.5315 g (depends on formulation) • Water - .023 g  23 uL • Catalyst – Tegoamine - .0682 g • Stabilizer – Turkey red oil - .023 g • Pore opener – Calcium stearine - .0625 g • Isocyanate – 1.323 g • Total mass = 3.0303 g • Hardener = 1.7073 g • Isocyanate = 1.323 g

  8. Desired Foam Properties • Porosity characteristics • Macroscopic observation • SEM imaging • Analyze PDI (uniformity) • Analyze pore size (200-600 um) • Mechanical characteristics (DMA) • Compressive stress • Compressive modulus • Young’s Modulus

  9. Procedure • In the OR, the polymer is stored as two separate components (hardener + isocyanate) • When needed, both elements will be added to the canister • The canister will then be inserted into the mixing fixture.

  10. Procedure • After mixing is complete, the canister is removed from the fixture. (Mixing time estimated 45 sec) • An attachment is then employed to move the mixture into an injection device. • Polymer is injected into the body • 5-10 minute working time depending on composition

  11. Current Budget Estimate • Agitator requires special manufacturing • All estimates are conservative

  12. Outside Advisor – Dr. Frank Papay • Personal practice – craniofacial plastic surgery using PMMA • Volume of injection between 5 and 35cc • Referenced Synthes Norian SRS as comparison

  13. FDA / IP Considerations • Class II device • 510(k) submission • Substantial equivalence to predicate device: • Has same technological characteristics OR • Has different technological characteristics but does not raise new questions of safety/efficacy

  14. Future Work for 510(k) Submission • Identify predicate device • Define equivalent characteristics/functions • Data to demonstrate why the differing characteristics/functions do not affect • Safety • Effectiveness

  15. Optimization of Impeller Design • Rushton turbine – radial flow impeller • Important parameters: • D/T ratio = 0.75 (D = impeller diameter; T = tank diameter) • 0.75” impeller OD : 1.00” tank diameter ID • Off-bottom clearance C = variable according to design

  16. Experimental Testing • Foams produced 3.12.08 / 3.13.08 • Testing parameters • 40-50 second mixing time • RPM between 5000 – 11000 • ~10 cc produced • Porosity and mechanical testing to be conducted within the coming week • Significant observations • Foam possessed equivalent macroscopic characteristics to previous foams

  17. Current Work • Evaluate results of first two mixes • Immediate obstacles: • Finalize canister • Create fixture (minimize size) http://www.postmixing.com/mixing%20forum/images/rt6.jpg

  18. Future Work • Experimental testing • Pinpoint mixing speed (5,000 – 15,000 RPM) • Pinpoint mixing time upon further testing (15 - 45 sec) • Develop a system for transferring mixture from canister to syringe • Mimic operating room conditions • Maintaining sterility throughout process

More Related